GlassScriptPhysician profile
Magen A Brailey
NPI 1316698053
$1,174.50
in general payments reported to CMS, 2019-2025
18 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $240 · 2023: $371 · 2024: $386 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $365.51 | 2022-2024 | Opdivo |
| Abbvie INC. | $147.19 | 2024-2025 | |
| Emd Serono, INC. | $121.84 | 2023 | Tepmetko |
| Janssen Biotech, INC. | $120.13 | 2022 | |
| Novartis Pharmaceuticals Corporation | $71.31 | 2023-2024 | |
| Pfizer INC. | $51.34 | 2023-2024 | |
| Aveo Pharmaceuticals, INC. | $45.31 | 2024-2025 | |
| Incyte Corporation | $36.21 | 2024-2025 | Jakafi, Niktimvo |
| Lilly USA, LLC | $31.07 | 2024 | Jaypirca, Retevmo, Verzenio |
| Dendreon Pharmaceuticals LLC | $26.06 | 2025 | Provenge |
| Takeda Pharmaceuticals U.S.A., INC. | $24.42 | 2024 | Fruzaqla |
| Pharmaessentia USA Corporation | $22.52 | 2024 | Besremi |
| Daiichi Sankyo INC. | $20.61 | 2024 | Enhertu |
| Stemline Therapeutics INC. | $19.83 | 2023 | Orserdu |
| Sun Pharmaceutical Industries INC. | $19.57 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $17.95 | 2025 | |
| Seagen INC. | $17.54 | 2023 | Tukysa |
| Amgen INC. | $16.09 | 2023 | Lumakras |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Magen Brailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.